A Phase-II Study Of TOMUDEX Plus Radiotherapy In Subject With Inoperable or Recurrent Rectal Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The pilot study is designed to investigate the value of Neo-adjuvant Tomudez in combination
with radiotherapy in patients with inoperable or recurrent rectal cancer in terms of response
rate and increasing the resectability of initially inoperable rectal cancer.